April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
The signal sequence of AMD-related variant Cystatin C is not sufficient for mistrafficking to mitochondria
Author Affiliations & Notes
  • Alessandro Riccio
    Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom
    Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore
  • Malcolm Jackson
    Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom
  • Walter Hunziker
    Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore
  • Luminita I Paraoan
    Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom
  • Footnotes
    Commercial Relationships Alessandro Riccio, None; Malcolm Jackson, None; Walter Hunziker, None; Luminita Paraoan, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 630. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alessandro Riccio, Malcolm Jackson, Walter Hunziker, Luminita I Paraoan; The signal sequence of AMD-related variant Cystatin C is not sufficient for mistrafficking to mitochondria. Invest. Ophthalmol. Vis. Sci. 2014;55(13):630.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The purpose of this study was to determine whether the signal peptide is alone responsible for the intracellular mislocalization of the age-related macular degeneration (AMD)-related variant Cystatin C in the retinal pigmented epithelium (RPE). Variant B cystatin C is generated by a point mutation in its leader sequence. As a consequence, this protein has been reported to divert from the secretory pathway to an unusual mitochondria association.

Methods: Constructs encoding green fluorescent protein (eGFP) N-terminally linked to the leader sequence from wild-type and variant B cystatin C were made. RPE cell lines expressing these constructs were used to analyze the intracellular distribution of the eGFP by cell imaging and immunoblotting. Cell fractions obtained by differential centrifugation and mitochondrial fractions obtained by magnetic separation were used in the analysis. eGFP secretion in conditioned media was analyzed by Western blotting to further define the role of the leader sequence in targeting the protein to the secretory pathway.

Results: Both wild-type and variant leader sequences directed the eGFP to the ER/secretory pathway in stark contrast to the leaderless eGFP. No significant difference in protein distribution between the two signal peptides was observed and in particular variant B leader peptide did not direct eGFP to mitochondria. However, although both constructs targeted eGFP for secretion, a reduction in the efficiency of this process was observed in the case of variant signal peptide. The experimental data supports the hypothesis that the reduced secretion of the variant protein is due to unfavourable interaction of its leader sequence (less hydrophobic) with components of the ER translocation channel and not to its loss of ER targeting.

Conclusions: The variant signal peptide is therefore not responsible alone for the mitochondria-association of variant B cystatin C. We conclude that this mislocalization is most likely due to changes of the chemical-physical properties of the whole precursor cystatin C protein sequence that probably alters the folding/conformation of cystatin C and, conversely, the conformational change may determine interactions with proteins involved in mitochondria localization. Understanding the molecular mechanism underlying this mistrafficking will help understand how it contributes to the impairment of RPE function.

Keywords: 412 age-related macular degeneration • 701 retinal pigment epithelium • 600 mitochondria  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×